Krishna Institute of Medical Sciences Ltd
Healthcare | Small Cap
Krishna Institute of Medical Sciences Ltd demonstrates a mixed financial performance. The company exhibits strong growth in revenue, operating profit, and assets. Its ability to cover interest expenses is also robust. Profitability is a notable strength, driven by healthy gross profit and operating margins, as well as a good return on assets. However, the company shows zero figures across liquidity metrics which raises concerns. The company maintains a strong equity position but also has zero debt. While the company shows growth, the net income growth rate is zero. The company's efficiency in utilizing fixed assets and capital appears to be low given the low turnover ratios. The healthcare industry is subject to regulatory changes and economic conditions, influencing operational strategies and financial results.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio4.00
- Profitability Ratio7.20
- Efficiency Ratio4.67
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourStrong Bullish
- 2 HoursStrong Bullish
- 4 HoursBullish
- 1 DayStrong Bullish
- 1 WeekBullish
- 1 MonthBullish
Krishna Institute of Medical Sciences Ltd demonstrates a mixed financial performance. The company exhibits strong growth in revenue, operating profit, and assets. Its ability to cover interest expenses is also robust. Profitability is a notable strength, driven by healthy gross profit and operating margins, as well as a good return on assets. However, the company shows zero figures across liquidity metrics which raises concerns. The company maintains a strong equity position but also has zero debt. While the company shows growth, the net income growth rate is zero. The company's efficiency in utilizing fixed assets and capital appears to be low given the low turnover ratios. The healthcare industry is subject to regulatory changes and economic conditions, influencing operational strategies and financial results.
Overall Valuation Score
P/E RATIO (TTM)
123.35
Industry Median
47.76
Small Cap Median
45.36
P/E RATIO
133.37
P/B RATIO
14.31
Industry Median
4.54
Small Cap Median
3.95
P/S RATIO
8.04
Industry Median
3.59
Small Cap Median
2.22
Others
PEG RATIO
0.00
EV/EBITDA RATIO
42.73
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹804.25 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company demonstrates strong growth in revenue, operating profit, earnings per share, and assets. This indicates successful expansion and effective management strategies. While the company shows growth, the net income growth rate is zero. Sustaining this growth trajectory will depend on continued innovation and effective capital management.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 24.14 | 33.13 | 13.65 | 21.5 | 28.67 |
| Operating Profit Growth Rate | 38.99 | 16.6 | 6.06 | 22.38 | 1.13 |
| Earnings Per Share (EPS) Growth | 60.31 | 1.08 | -7.85 | 24 | -37.25 |
| Asset Growth Rate | 32.87 | 52.36 | 31.68 | 48.93 | 36.39 |
| Net Income Growth Rate | 67.8 | 6.4 | -8.2 | 23.51 | -41.69 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios present a mixed view. While capital expenditure is average, the ratios for adjusted earnings per share and dividend per share are low. The company's cash earnings per share is weak and book value per share is also weak. Improving earnings and optimizing capital structure could enhance the financial health.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 8.93 | 9.57 | 9 | 10.65 | 6.25 |
| Cash Earnings Per Share (Cash EPS) | 10.43 | 12.38 | 12.07 | 14.8 | 13.12 |
| Book Value Per Share | 34.67 | 41.75 | 45.7 | 53.45 | 56.17 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 170 | 572 | 646 | 962 | 1413 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company exhibits strong profitability, particularly in gross profit margin, return on assets, and operating margin. Profitability in its core operations drives financial health and investor returns. While the company shows strong profitability, the return on equity and net margin is weak.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.32 | 21.93 | 20.06 | 20.3 | 13.29 |
| Return on Capital Employed (ROCE) | 34 | 24 | 17 | 15 | 9 |
| Return on Equity (ROE) | 24.8 | 21.92 | 18.38 | 19.41 | 10.77 |
| Return on Assets (ROA) | 27.52 | 21.06 | 16.96 | 13.94 | 10.34 |
| Operating Margin | 31.74 | 27.8 | 25.94 | 26.13 | 20.54 |
| Net Margin | 20.84 | 16.65 | 13.45 | 13.67 | 6.2 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios present a mixed picture. While the days sales in inventory and receivable days are average, the turnover ratios for fixed assets, inventory, receivables, and capital are very low. Efficiently managing capital and assets is vital for optimizing resource use and return on investment. Improving these ratios could lead to better profitability and operational effectiveness.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.64 | 1.24 | 1.03 | 0.91 | 0.68 |
| Inventory Turnover Ratio | 39.97 | 43.44 | 43.41 | 42.81 | 42.06 |
| Receivables Turnover Ratio | 13.82 | 11.51 | 9.13 | 8.81 | 8.23 |
| Days Sales in Inventory Ratio | 9.13 | 8.4 | 8.41 | 8.53 | 8.68 |
| Receivable Days | 26.41 | 31.71 | 39.98 | 41.43 | 44.35 |
| Capital Turnover Ratio | 1.02 | 0.95 | 0.82 | 0.68 | 0.66 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company demonstrates a strong ability to cover its interest expenses, but has no equity dividend coverage. The company's capacity to handle debt obligations is a positive sign. Focusing on consistent profitability will further strengthen coverage ratios.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 21.77 | 14.11 | 9.36 | 6.58 | 2.65 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is marked by a strong equity base and negligible debt. The company's has a strong position with its assets entirely financed by equity. While this indicates financial stability, it might also suggest a missed opportunity to leverage debt for growth or higher returns, especially when interest rates are favorable.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.14 | 0.28 | 0.4 | 0.52 | 0.62 |
| Debt to Equity Ratio | 0.16 | 0.39 | 0.67 | 1.08 | 1.63 |
| Equity Ratio | 0.86 | 0.72 | 0.6 | 0.48 | 0.38 |
| Debt To Asset Ratio | 0.12 | 0.22 | 0.32 | 0.41 | 0.47 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position reflects an inability to meet its short-term obligations using its current assets. The ratios being zero across the board is a significant cause for concern. This suggests potential difficulties in managing day-to-day expenses and unexpected financial needs. While a conservative approach to leveraging short-term assets might be a reason, ensuring sufficient liquid assets is crucial for operational stability.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.93 | 1 | 0.83 | 0.82 | 0.73 |
| Quick Ratio | 1.8 | 0.93 | 0.77 | 0.77 | 0.68 |
| Cash Ratio | 0.67 | 0.11 | 0.06 | 0.06 | 0.04 |
| Operating Cash Flow Ratio | 1.14 | 0.73 | 0.69 | 0.47 | 0.28 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Narayana Hrudayalaya Ltd | 6.82 | 47.66 | Neutral | 1611.00 | 24.62 | 806.00 |
| 2 | Krishna Institute of Medical Sciences Ltd | 5.93 | 133.37 | Neutral | 802.00 | 6.52 | 242.00 |
| 3 | Rainbow Childrens Medicare Ltd | 5.74 | 53.68 | Neutral | 544.00 | 24.62 | 282.00 |
Krishna Institute of Medical Sciences Ltd. demonstrates mixed management effectiveness. Strong revenue growth contrasts with profit growth inconsistencies. Increasing debt and a high P/E ratio raise concerns. While institutional interest is stable, a declining ROCE% indicates potential capital efficiency issues. The management shows competence in revenue generation but faces challenges in financial prudence and maintaining profitability.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Strong Sales Growth | 21% | Consistent revenue expansion |
| Institutional Interest | Stable FII/DII Holding | Remains attractive to institutional investors | |
| CONS | Increasing Debt | ₹ 2,557 Cr. | Rising leverage |
| High P/E Ratio | 72.1 | Potential overvaluation |
Financial Performance & Growth
Krishna Institute of Medical Sciences shows strong revenue growth but struggles to maintain consistent profit growth. Compounded sales growth indicates a positive trend. Sales growth is robust, with a TTM of 21%. Compounded profit growth shows a declining trend over recent years. OPM% has fluctuated, indicating variability in operational efficiency. YOY Profit Growth % has also been inconsistent, with significant variations across quarters, suggesting instability in earnings. Reliance on other income remains relatively low. These factors suggest that while the company is growing its sales effectively, maintaining consistent profit margins and earnings stability is an ongoing challenge.
| Metric | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Sales Growth (%) | 26.31% | 27.13% | 33.13 | 13.67 | 21.49 |
Capital Efficiency & Returns
The capital efficiency and returns of Krishna Institute of Medical Sciences show a mixed performance. ROCE % has fluctuated over the years, showing a recent decline. ROE % also demonstrates a similar pattern. The cash conversion cycle (CCC) has varied, indicating fluctuations in working capital management efficiency. While the company has shown periods of strong capital efficiency, recent declines in ROCE and ROE, along with fluctuations in the cash conversion cycle, indicate areas needing attention to ensure sustainable and efficient use of capital.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 20% | 29% | 34% | 24% | 17% | 15% |
Financial Health & Prudence
Krishna Institute of Medical Sciences shows concerning trends in its financial health and prudence. Borrowings have significantly increased over the years. The debt-to-equity ratio has also risen, reflecting higher leverage. The interest coverage ratio, while still positive, has decreased. The company has maintained a dividend payout of 0%, indicating a focus on reinvesting profits rather than distributing them to shareholders. The increasing debt levels and decreasing interest coverage ratio raise concerns about the company's ability to comfortably meet its interest obligations. These indicators suggest that the company's financial health is under pressure, requiring careful monitoring.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 369 | 316 | 257 | 678 | 1355 | 2557 |
| Interest Coverage | 3.20 | 7.54 | 23.82 | 16.51 | 11.78 | 8.70 |
Shareholding & Ownership Structure
The shareholding and ownership structure of Krishna Institute of Medical Sciences indicates a stable promoter holding and strong institutional interest. The promoter holding has remained consistent over the past few years. There has been an increase in FII holding over the past few years. DII holding has also increased, indicating growing confidence from domestic institutional investors. This ownership structure suggests a strong alignment between management and shareholders, as well as confidence from institutional investors in the company's prospects.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 38.84 | 38.85 | 38.82 | 38.82 |
| FII Holding (%) | 8.91 | 19.41 | 16.73 | 15.44 |
| DII Holding (%) | 21.02 | 29.76 | 33.13 | 31.95 |
KIMS exhibits moderate risk. Sales growth is strong, but profit growth is inconsistent. High debt levels coupled with fluctuating ROCE% pose financial challenges. The increasing debt and interest coverage warrant caution. The company’s accounting quality doesn’t raise immediate red flags, but trends in debt and profitability should be closely monitored. These factors combine to indicate an environment where risks are present but manageable.
Accounting quality red flags
Based on the provided data, there are no immediate accounting red flags, but trends in debt and profitability should be closely monitored
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10797.00Bullish
- SMA 20793.71Bullish
- SMA 50782.61Bullish
- EMA 10798.77Bullish
- EMA 20793.83Bullish
- EMA 50786.06Bullish
- DEMA 10804.32Bullish
- DEMA 20801.40Bullish
- DEMA 50795.11Bullish
- TEMA 10805.78Bullish
- TEMA 20804.24Bullish
- TEMA 50797.86Bullish
- MACD5.91Bullish
- ADX33.90Strong Trend
- IndicatorValueSignal
- RSI68.06Neutral
- CCI176.80Overbought
- ROC 92.34Bullish
- ROC 141.79Bullish
- ROC 254.83Bullish
- Stoch K75.33Neutral
- Stoch D77.67Neutral
- IndicatorValueSignal
- BB Upper805.63Overbought
- BB Middle793.71Neutral
- BB Lower781.78Neutral
- ATR8.58Low Volatility
- IndicatorValueSignal
- MFI77.60Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10795.31Bullish
- SMA 20785.89Bullish
- SMA 50780.17Bullish
- EMA 10795.56Bullish
- EMA 20789.54Bullish
- EMA 50779.88Bullish
- DEMA 10802.91Bullish
- DEMA 20798.10Bullish
- DEMA 50793.73Bullish
- TEMA 10805.23Bullish
- TEMA 20801.75Bullish
- TEMA 50793.30Bullish
- MACD6.91Bullish
- ADX38.14Strong Trend
- IndicatorValueSignal
- RSI66.64Neutral
- CCI144.28Overbought
- ROC 91.16Bullish
- ROC 144.79Bullish
- ROC 255.58Bullish
- Stoch K79.11Neutral
- Stoch D77.08Neutral
- IndicatorValueSignal
- BB Upper809.20Neutral
- BB Middle785.89Neutral
- BB Lower762.57Neutral
- ATR11.76Low Volatility
- IndicatorValueSignal
- MFI88.39Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10785.88Bullish
- SMA 20782.98Bullish
- SMA 50767.65Bullish
- EMA 10789.91Bullish
- EMA 20782.73Bullish
- EMA 50764.35Bullish
- DEMA 10798.54Bullish
- DEMA 20794.08Bullish
- DEMA 50797.93Bullish
- TEMA 10802.09Bullish
- TEMA 20795.72Bullish
- TEMA 50N/AN/A
- MACD8.91Bullish
- ADX30.45Strong Trend
- IndicatorValueSignal
- RSI65.59Neutral
- CCI168.64Overbought
- ROC 94.19Bullish
- ROC 145.46Bullish
- ROC 258.98Bullish
- Stoch K78.07Neutral
- Stoch D73.11Neutral
- IndicatorValueSignal
- BB Upper805.80Overbought
- BB Middle782.98Neutral
- BB Lower760.15Neutral
- ATR17.97High Volatility
- IndicatorValueSignal
- MFI78.55Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10783.53Bullish
- SMA 20772.94Bullish
- SMA 50728.83Bullish
- SMA 100693.65Bullish
- SMA 200691.51Bullish
- EMA 10783.82Bullish
- EMA 20771.77Bullish
- EMA 50739.50Bullish
- EMA 100712.68Bullish
- EMA 200690.69Bullish
- DEMA 10794.98Bullish
- DEMA 20795.13Bullish
- DEMA 50780.69Bullish
- DEMA 100745.03Bullish
- DEMA 200729.39Bullish
- TEMA 10796.77Bullish
- TEMA 20794.51Bullish
- TEMA 50799.97Bullish
- TEMA 100770.29Bullish
- TEMA 200724.43Bullish
- MACD16.99Bullish
- ADX33.28Strong Trend
- IndicatorValueSignal
- RSI60.90Neutral
- CCI135.70Overbought
- ROC 146.68Bullish
- ROC 254.00Bullish
- Stoch K81.09Overbought
- Stoch D73.41Neutral
- IndicatorValueSignal
- BB Upper808.65Neutral
- BB Middle772.94Neutral
- BB Lower737.24Neutral
- ATR28.04High Volatility
- IndicatorValueSignal
- MFI66.36Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20690.86Bullish
- SMA 50695.28Bullish
- EMA 20708.48Bullish
- EMA 50679.03Bullish
- DEMA 20739.65Bullish
- DEMA 50724.91Bullish
- TEMA 20765.28Bullish
- TEMA 50713.68Bullish
- MACD27.69Bullish
- ADX23.01Weak Trend
- IndicatorValueSignal
- RSI60.50Neutral
- CCI140.02Overbought
- ROC 148.95Bullish
- ROC 2522.81Bullish
- Stoch K88.28Overbought
- Stoch D86.67Overbought
- IndicatorValueSignal
- BB Upper810.85Neutral
- BB Middle690.86Neutral
- BB Lower570.87Neutral
- ATR52.89Low Volatility
- IndicatorValueSignal
- MFI70.82Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6667.41Bullish
- SMA 12688.29Bullish
- SMA 24625.49Bullish
- EMA 6690.56Bullish
- EMA 12671.08Bullish
- EMA 24617.00Bullish
- DEMA 6707.98Bullish
- DEMA 12712.65Bullish
- DEMA 24729.62Bullish
- TEMA 6717.31Bullish
- TEMA 12698.91Bullish
- TEMA 24N/AN/A
- MACD137.43Bearish
- ADX41.25Strong Trend
- IndicatorValueSignal
- RSI63.42Neutral
- CCI120.02Overbought
- ROC 2586.60Bullish
- ROC 50174.31Bullish
- Stoch K77.73Neutral
- Stoch D82.13Overbought
- IndicatorValueSignal
- BB Upper787.34Neutral
- BB Middle655.14Neutral
- BB Lower522.95Neutral
- ATR96.98High Volatility
- IndicatorValueSignal
- MFI54.48Neutral